AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -20.0% | 196 | +18.1% | 0.00% | – |
| Q1 2022 | $5,000 | – | 166 | +1975.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 8 | -75.0% | 0.00% | – |
| Q3 2021 | $1,000 | -97.0% | 32 | -94.7% | 0.00% | – |
| Q2 2021 | $33,000 | -62.9% | 603 | -65.1% | 0.00% | -100.0% |
| Q1 2021 | $89,000 | +48.3% | 1,728 | +25.1% | 0.00% | 0.0% |
| Q4 2020 | $60,000 | +22.4% | 1,381 | -1.4% | 0.00% | 0.0% |
| Q3 2020 | $49,000 | -34.7% | 1,401 | +4.2% | 0.00% | 0.0% |
| Q2 2020 | $75,000 | – | 1,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |